Study of sulthiame in people with kidney impairment and healthy controls
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests an investigational drug called sulthiame in people with mild or moderate kidney disease and in healthy volunteers. It helps researchers learn how the drug is processed when kidneys are not working normally, which can guide future dosing for patients with kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must weigh at least 110 lbs (50 kg) for women or 132 lbs (60 kg) for men, with a BMI between 18.5 and 40.
- You must have mild, moderate, or normal kidney function, depending on the group you join.
- If you have kidney disease, your medication doses must be stable (no changes) for 14 days before the study starts.
- You cannot have significant liver disease, unstable kidney function, or a history of certain stomach surgeries.
- You must not have taken another investigational drug within 28 days or 5 half-lives before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
This study tests how the body handles an investigational drug called PKN605 in people with different levels of kidney function. It aims to see if the drug is safe and how it is processed when kidneys are impaired, which can help doctors decide the right dose for people with kidney disease.
This study looks at how the kidneys work in both healthy people and those with reduced kidney function. Researchers want to understand kidney health better to help people in the future.
This study tests a new medicine called KS101 to see if it is safe and how it works in healthy people for the first time. It is a first-in-human trial, meaning this is the first time the drug is given to people, and your health will be closely monitored throughout.
This study tests an experimental drug called INCB161734 in people with severe kidney disease or those on dialysis. It aims to see how the drug behaves in the body and if it is safe.
Hear when a new Renal Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.